Ecrg4 contributes to the anti-glioma immunosurveillance through type-I interferon signaling

about

Ecrg4 peptide is the ligand of multiple scavenger receptors.

P2860

Q52728417-6F555680-2604-4CD1-945C-DF56771E460F

P2860

Ecrg4 contributes to the anti-glioma immunosurveillance through type-I interferon signaling

Item

http://www.wikidata.org/entity/Q42180788

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Ecrg4 contributes to the anti- ...... gh type-I interferon signaling

@en

Ecrg4 contributes to the anti- ...... gh type-I interferon signaling

@nl

type

Item

label

Ecrg4 contributes to the anti- ...... gh type-I interferon signaling

@en

Ecrg4 contributes to the anti- ...... gh type-I interferon signaling

@nl

prefLabel

Ecrg4 contributes to the anti- ...... gh type-I interferon signaling

@en

Ecrg4 contributes to the anti- ...... gh type-I interferon signaling

@nl

P1476

Ecrg4 contributes to the anti- ...... gh type-I interferon signaling

@en

P2093

Hidemitsu Kitamura

http://www.w3.org/2001/XMLSchema#string

Kei Enomoto

http://www.w3.org/2001/XMLSchema#string

Shuji Takeda

http://www.w3.org/2001/XMLSchema#string

Shun Kaneumi

http://www.w3.org/2001/XMLSchema#string

Tetsuro Miki

http://www.w3.org/2001/XMLSchema#string

Toru Kondo

http://www.w3.org/2001/XMLSchema#string

Uichi Koshimizu

http://www.w3.org/2001/XMLSchema#string

P2860

Glioblastoma formation from cell population depleted of Prominin1-expressing cells

Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

Interferons, immunity and cancer immunoediting

Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression

Paradoxical roles of the immune system during cancer development

The M1 and M2 paradigm of macrophage activation: time for reassessment

Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

P304

e1242547

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2016.1242547

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tetsuo Moriguchi

Shyam K Mishra

P577

2016-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28123880

http://www.w3.org/2001/XMLSchema#string

P932

5214586

http://www.w3.org/2001/XMLSchema#string

Ecrg4 contributes to the anti-glioma immunosurveillance through type-I interferon signaling

about

P2860

P2860

Ecrg4 contributes to the anti-glioma immunosurveillance through type-I interferon signaling

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932